Información del artículo
El Texto completo está disponible en PDF
References
[1.]
W.A. High, J.B. Cohen, W. Wetherington, C.J. Cockerell.
Superficial gyrate erythema as a cutaneous reaction to alendronate for osteoporosis.
J Am Acad Dermatol, 48 (2003), pp. 945-946
[2.]
K. Krasagakis, S. Kruger-Krasagakis, D. Ioannidou, A. Tosca.
Chronic erosive and ulcerative oral lesion caused by incorrect administration of alendronate.
J Am Acad Dermatol, 50 (2004), pp. 651-652
[3.]
A. Dicko, A. Toulemonde, F. Hoareau, M. Avenel-Audran, J.L. Verret.
Ulcérations buccales.
Ann Dermatol Venereol, 134 (2007), pp. 389-390
[4.]
N. Demerjian, G. Bolla, A. Spreux.
Severe oral ulcerations induced by alendronate.
Clin Rheumatol, 18 (1999), pp. 349-350
[5.]
P.C. De Groen, D.F. Lubbe, L.J. Hirsch, A. Daifotis, W. Stephenson, D. Freedholm, et al.
Esophagitis associated with the use of alendronate.
N Engl J Med, 335 (1996), pp. 1016-1021
[6.]
S.L. Nightingale.
Important information regarding alendronate adverse reactions.
JAMA, 20 (1996), pp. 1534
[7.]
D.Y. Graham, H.M. Malaty, R. Goodgame.
Primary amino-biphosphonates: a new class of gastrotoxic drugs-comparison of alendronate and aspirin.
Am J Gastroenterol, 92 (1997), pp. 1322-1325
[8.]
J.L. Schmutz, A. Barbaud, P. Trechot.
Alendronate et ulcérations buccales: d’abord bien interroger le patient.
Ann Dermatol Venereol, 132 (2005), pp. 930
Copyright © 2009. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
